Please login to the form below
Apadaz
This page shows the latest Apadaz news and features for those working in and with pharma, biotech and healthcare.
FDA panel backs Pfizer and Teva abuse-resistant painkillers
Last month the same panel also rejected an abuse-deterrent claim for KemPharm's Apadaz (benzhydrocodone hydrochloride and acetaminophen) whilst backing approval of the drug.
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Account Manager (PR)
-
Great Benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account Manager
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director, Medical Education
-
Salary TBC
-
Publications director
-
Competitive salary and bonus scheme
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Merck KGaA divests allergy business to Dermapharm
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Genital herpes vaccine candidate heads for human studies
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
- How will the Tories’ historic win shape the NHS?
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Quick links
Infographics
